Correlation with known diffuse large B-cell lymphoma markers showed that high expression of MYC, BCL2, and ENO3 was associated with worse outcome [27] (Figure 10 and Figure 11). The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.